A Discussion of COPD Surveillance Data

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Earl S. Ford, MD, MPH and David M. Mannino, MD, FCCP, discuss their study of surveillance results for COPD in the United States from 1999 to 2011 with CHEST podcast editor D. Kyle Hogarth, MD, FCCP.

To listen to this podcast, click here.
Related Articles
Up to 13% of patients considered to have chronic obstructive pulmonary disease (COPD) under current criteria were recently found to be misdiagnosed.
Here are new drugs for 2015 that pharmacists can expect to handle.
Everyday walking is the most commonly reported problematic daily activity for patients with chronic obstructive pulmonary disease (COPD).
Warfarin remains a cornerstone anticoagulant for a number of reasons that include its low cost at the pharmacy counter.
Latest Issues
$auto_registration$